URCH Publishing: GlaxoSmithKline Will Overtake Pfizer to Become World's Largest Pharmaceutical Company by 2012
J&J and Merck Forecast for Stagnant Growth, Notes URCH Publishing
LONDON--(BUSINESS WIRE)--There will be major changes in the global pharmaceutical market and key changes in the top ten company list by 2012, says a new report from URCH Publishing, a leading provider of pharmaceutical industry business information.
The report, Pharmaceutical Market Trends, 2008 - 2012 - Key market forecasts and growth opportunities, which is published today, forecasts that Pfizer will fall from first to third place in the coveted list. The list in 2012 will be headed by GlaxoSmithKline (GSK) followed by Roche. Pfizer was the leading company in 2007 with a market share of 6.2%. GSK was in second position with a 5.4% market share and Roche held a share of 4.3%.
The top ten companies, ranked by pharmaceutical sales, generated total sales of $284 billion in 2007. "Total pharmaceutical sales from these companies accounted for more than 40% of the total market," said Steve Seget the report's author. "However, only two of the top ten pharmaceutical corporations in 2007 are forecast to grow at a rate above the overall pharmaceutical market over the next five years; Roche with a CAGR of 6.2% and Novartis with a CAGR of 6.1%," he added.
The report also concludes that Johnson & Johnson and Merck will suffer stagnant growth in the four year period.
The global pharmaceutical market is forecast to grow to $929 billion in 2012, an equivalent CAGR of 5.5% over the next four years. The 142 page study says future sales growth will remain limited by high prescription drug co-pays for insured consumers, the growing availability of generic drugs and a lack of new blockbuster drugs to replace the leading products scheduled to lose patent protection.